“Maxion Therapeutics | We are using our revolutionary KnotBody® technology to create first-in-class and best-in-class protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases.”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Balance sheet as at 31 December 2025 · small accounts
| 2025 | 2024 | 2022 | 2021 | |
|---|---|---|---|---|
| Fixed Assets | £1,248,240 | £1,027,967 | £60,074 | £54,250 |
| Current Assets | £52,536,139 | £4,780,149 | £498,727 | £124,519 |
| Debtors | £4,015,377 | £1,323,131 | £238,506 | £39,868 |
| Cash | £48,520,762 | £3,457,018 | £260,221 | £84,651 |
| Creditors (< 1 year) | £2,838,988 | £743,625 | £646,626 | £314,856 |
| Net Current Assets | £49,697,151 | £4,036,524 | (£147,899) | (£190,337) |
| Net Assets | (£136,087) | |||
| Shareholder Funds | £50,945,391 | £5,064,491 | (£87,825) | (£136,087) |
Filing history not loaded yet. See it on Companies House
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →